New Drug Could Improve Treatment for Pulmonary Arterial Hypertension

An oral medication for pulmonary arterial hypertension led to a substantial reduction in patients’ hospitalization and worsening symptoms, according to a study published in the New England Journal of Medicine. The drug, Selexipag, gained U.S. Food and Drug Administration approval in December. It is now available for patients. The data, from the largest study ever… Continue reading New Drug Could Improve Treatment for Pulmonary Arterial Hypertension

COPD Patients Don’t Know Enough About The Illness

A new national survey of patients with chronic obstructive pulmonary disease (COPD) shows a surprising lack of awareness of risk factors and knowledge of diagnosis stage. That lack of knowledge, researchers says, has a significant impact on patients’ quality of life, employment and ability to afford treatment. COPD, the third most common cause of death… Continue reading COPD Patients Don’t Know Enough About The Illness